{"database":"GEO","file_versions":[{"headers":{"Content-Type":["application/json"]},"body":{"files":{"Other":["ftp://ftp.ncbi.nlm.nih.gov/geo/series/GSE328nnn/GSE328508/"]},"type":"primary"},"statusCode":"OK","statusCodeValue":200}],"scores":null,"additional":{"omics_type":["Transcriptomics"],"species":["Homo sapiens"],"gds_type":["Expression profiling by high throughput sequencing"],"full_dataset_link":["https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE328508"],"repository":["GEO"],"entry_type":["GSE"],"additional_accession":[]},"is_claimable":false,"name":"High-throughout sequencing of ovarian cancer cells treated with T-oligo","description":"After treating human ovarian cancer cells ES2 with T-oligo G4+RHPS4, high-throughput sequencing technology was employed. The transcriptome analysis revealed that T-oligo G4+RHPS4 does not exert its anti-tumor effect solely through telomere dysfunction, but instead simultaneously regulates cell cycle, senescence, and metabolic-related signaling pathways, thereby synergistically inducing the death of ovarian cancer cells.","dates":{"publication":"2026/04/23"},"accession":"GSE328508","cross_references":{"GSM":["GSM9684555","GSM9684554","GSM9684553","GSM9684552","GSM9684551","GSM9684550"],"GPL":["24676"],"GSE":["328508"],"taxon":["Homo sapiens"]}}